Scarica l'app Stockscreener
177.14
2.32%
4.01
Dopo l'orario di chiusura:
177.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie
Ligand Pharmaceuticals IncorporatedEquity Right (LGNYZ) Price Target Increased by 410.53% to 0.05 - Nasdaq
Ligand Pharmaceuticals stock hits 52-week high at $172.49 By Investing.com - Investing.com Canada
Can Ligand Pharmaceuticals Incorporated stock deliver sustainable ROE2025 Short Interest & Long-Term Safe Investment Plans - newser.com
What drives Ligand Pharmaceuticals Incorporated LGDN stock priceBollinger Bands Signals & Affordable Stock Market Tips - earlytimes.in
What drives Ligand Pharmaceuticals Incorporated stock priceHead and Shoulders Patterns & Small Budget Capital Gains - Early Times
What analysts say about Ligand Pharmaceuticals Incorporated LGDN stockDividend Reinvestment Plans & Small Investment Growth Tips - Early Times
Ligand Pharmaceuticals Hits New 52-Week High of $170.78 - Markets Mojo
Ligand Pharmaceuticals Hits New 52-Week High of $172.45 - Markets Mojo
Congress Asset Management Co. Raises Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals director Aryeh sells $1.7 million in shares By Investing.com - Investing.com Australia
LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor - GuruFocus
Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln - MarketScreener
Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 - GlobeNewswire Inc.
Ligand Pharmaceuticals director Aryeh sells $1.7 million in shares - Investing.com
Ligand Pharmaceuticals (NASDAQ:LGND) Hits New 12-Month HighTime to Buy? - MarketBeat
Contravisory Investment Management Inc. Acquires New Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analysts Set Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) PT at $176.50 - MarketBeat
Strs Ohio Takes Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
What earnings revisions data tells us about Ligand Pharmaceuticals IncorporatedJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com
Jobs Data: What is the dividend yield of Ligand Pharmaceuticals IncorporatedQuarterly Portfolio Report & Smart Allocation Stock Tips - khodrobank.com
Is now a turning point for Ligand Pharmaceuticals IncorporatedTrade Analysis Summary & Weekly Market Pulse Updates - newser.com
Will Ligand Pharmaceuticals Incorporated rebound enough to break even2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Aug Setups: Is Ligand Pharmaceuticals Incorporated in a long term uptrendMarket Performance Summary & Capital Efficient Trading Techniques - خودرو بانک
Rate Cut: Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWatch List & Advanced Swing Trade Entry Alerts - خودرو بانک
Earnings visualization tools for Ligand Pharmaceuticals Incorporated2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Ligand Pharmaceuticals stock hits 52-week high at $169.72 By Investing.com - Investing.com Canada
Rhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analyzing Ligand Pharmaceuticals (NASDAQ:LGND) and Provectus Biopharmaceuticals (OTCMKTS:PVCT) - Defense World
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Rating of “Buy” by Analysts - Defense World
Volume Recap: Is Ligand Pharmaceuticals Incorporated being accumulated by smart money2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - خودرو بانک
Aug Final Week: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandPortfolio Risk Report & Weekly Setup with High ROI Potential - خودرو بانک
Using data filters to optimize entry into Ligand Pharmaceuticals IncorporatedForecast Cut & Free Growth Oriented Trading Recommendations - newser.com
Aug Rallies: Will Ligand Pharmaceuticals Incorporated outperform the market in YEARJuly 2025 Momentum & Stepwise Entry and Exit Trade Signals - خودرو بانک
Aug Fed Impact: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandJuly 2025 Rallies & Stock Portfolio Risk Management - خودرو بانک
Ellsworth Advisors LLC Acquires Shares of 7,272 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals entered third amendment to credit agreementSEC filing - MarketScreener
Ligand Pharmaceuticals Entered Third Amendment To Credit AgreementSEC Filing - TradingView
Earnings Risk: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investorsMarket Performance Summary & Daily Oversold Stock Bounce Ideas - خودرو بانک
Pullback Watch: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک
Growth Value: What is Ligand Pharmaceuticals Incorporated’s TAM (Total Addressable Market)Entry Point & Consistent Income Trade Recommendations - خودرو بانک
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Increase in Short Interest - MarketBeat
Market Moves: What is the next catalyst for Ligand Pharmaceuticals IncorporatedJuly 2025 Breakouts & Daily Profit Focused Stock Screening - خودرو بانک
What’s the recovery path for long term holders of Ligand Pharmaceuticals IncorporatedJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Real time social sentiment graph for Ligand Pharmaceuticals IncorporatedJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Baird Financial Group Inc. - MarketBeat
Visual analytics tools that track Ligand Pharmaceuticals Incorporated performanceTrade Exit Summary & Verified Short-Term Plans - newser.com
Jacobs Levy Equity Management Inc. Makes New $16.53 Million Investment in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):